Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis
Haiyan Chen, Danting Shen, Dong‐Ze Ji, et al.
Gut (2018) Vol. 68, Iss. 3, pp. 512-521
Closed Access | Times Cited: 335

Showing 1-25 of 335 citing articles:

Global burden of liver disease: 2023 update
Harshad Devarbhavi, Sumeet K. Asrani, Juan Pablo Arab, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 516-537
Open Access | Times Cited: 865
Estimating the Global Prevalence, Disease Progression, and Clinical Outcome of Hepatitis Delta Virus Infection
Zhijiang Miao, Shaoshi Zhang, Xumin Ou, et al.
The Journal of Infectious Diseases (2019) Vol. 221, Iss. 10, pp. 1677-1687
Open Access | Times Cited: 270
Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease
Stephan Urban, Christoph Neumann‐Haefelin, Pietro Lampertico
Gut (2021) Vol. 70, Iss. 9, pp. 1782-1794
Open Access | Times Cited: 174
EASL Clinical Practice Guidelines on hepatitis delta virus
Maurizia Rossana Brunetto, G. Ricco, Francesco Negro, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 433-460
Open Access | Times Cited: 129
The changing context of hepatitis D
Mario Rizzetto, Saeed Hamid, F. Negro
Journal of Hepatology (2021) Vol. 74, Iss. 5, pp. 1200-1211
Open Access | Times Cited: 126
Hepatitis B Virus-Associated Hepatocellular Carcinoma
Giacomo Emanuele Maria Rizzo, Giuseppe Cabibbo, Antonio Craxı̀
Viruses (2022) Vol. 14, Iss. 5, pp. 986-986
Open Access | Times Cited: 116
Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial
Heiner Wedemeyer, Katrin Schöneweis, Pavel Bogomolov, et al.
The Lancet Infectious Diseases (2022) Vol. 23, Iss. 1, pp. 117-129
Closed Access | Times Cited: 98
Chronic hepatitis D and hepatocellular carcinoma: A systematic review and meta-analysis of observational studies
Dulce Alfaiate, Sophie Clément, Diana Gomes, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 3, pp. 533-539
Closed Access | Times Cited: 137
Viral Hepatitis
Simone Lanini, Andrew Ustianowski, Raffaella Pisapia, et al.
Infectious Disease Clinics of North America (2019) Vol. 33, Iss. 4, pp. 1045-1062
Closed Access | Times Cited: 126
Prevalence of Hepatitis B and Hepatitis D Virus Infections in the United States, 2011–2016
Eshan U. Patel, Chloe L. Thio, Denali Boon, et al.
Clinical Infectious Diseases (2019) Vol. 69, Iss. 4, pp. 709-712
Open Access | Times Cited: 122
Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta
Dominique Roulot, Ségolène Brichler, Richard Layese, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 5, pp. 1046-1062
Open Access | Times Cited: 115
Viral hepatitis and pregnancy
Norah A. Terrault, Miriam Levy, Ka Wang Cheung, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 18, Iss. 2, pp. 117-130
Closed Access | Times Cited: 111
A review on hepatitis D: From virology to new therapies
Nathalie Mentha, Sophie Clément, Francesco Negro, et al.
Journal of Advanced Research (2019) Vol. 17, pp. 3-15
Open Access | Times Cited: 104
Rate and impact of duodenoscope contamination: A systematic review and meta-analysis
Sára Larsen, Rasmus Vinther Russell, Lotte Ockert, et al.
EClinicalMedicine (2020) Vol. 25, pp. 100451-100451
Open Access | Times Cited: 81
Viral hepatitis update: Progress and perspectives
María Belén Pisano, Cecilia Graciela Giadans, Diego Flichman, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 26, pp. 4018-4044
Open Access | Times Cited: 67
Hepatitis D
Francesco Negro, Anna S. Lok
JAMA (2023) Vol. 330, Iss. 24, pp. 2376-2376
Closed Access | Times Cited: 40
Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries
Homie Razavi, Marı́a Buti, Norah A. Terrault, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 576-580
Open Access | Times Cited: 36
Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories
Devin Razavi‐Shearer, Hannah Child, K. Razavi-Shearer, et al.
Journal of Hepatology (2023) Vol. 80, Iss. 2, pp. 232-242
Open Access | Times Cited: 32
Hepatitis Delta Virus and Hepatocellular Carcinoma
Daniele Lombardo, Maria Stella Franzè, Giuseppe Caminiti, et al.
Pathogens (2024) Vol. 13, Iss. 5, pp. 362-362
Open Access | Times Cited: 9
Hepatitis B Vaccine: Four Decades on
Maria Mironova, Marc G. Ghany
Vaccines (2024) Vol. 12, Iss. 4, pp. 439-439
Open Access | Times Cited: 8
Editorial: Hepatitis D Screening—DAS (Delta Virus Awareness and Screening) Approach in Primary Care
Noreen Singh, Mang Ma
Alimentary Pharmacology & Therapeutics (2025) Vol. 61, Iss. 4, pp. 723-724
Closed Access | Times Cited: 1
Prevalence of HDV, HCV, and HIV Infection in the Population of Patients Infected with HBV in a Romanian Cohort
Antoanela Curici, Olivia Mioara Ilie, Dana Elena Mîndru
Microorganisms (2025) Vol. 13, Iss. 1, pp. 118-118
Open Access | Times Cited: 1
Liver diseases: epidemiology, causes, trends and predictions
Can Gan, Yuan Yuan, Haiyuan Shen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Chronic hepatitis delta virus infection leads to functional impairment and severe loss of MAIT cells
Joana Dias, Julia Hengst, Tiphaine Parrot, et al.
Journal of Hepatology (2019) Vol. 71, Iss. 2, pp. 301-312
Open Access | Times Cited: 74
Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139‐Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection
Michel Bazinet, Victor Pântea, Valentin Cebotarescu, et al.
Hepatology Communications (2020) Vol. 5, Iss. 2, pp. 189-202
Open Access | Times Cited: 69
Page 1 - Next Page

Scroll to top